First Allied Advisory Services’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,550
Closed -$203K 1564
2017
Q3
$203K Buy
+6,550
New +$203K 0.01% 1015